More articles from Review

  • Advance care planning: Beyond the living will
    Barbara J. Messinger-Rapport, MD, PhD, Elizabeth E. Baum, MD and Martin L. Smith, STD
    Cleveland Clinic Journal of Medicine May 2009, 76 (5) 276-285; DOI: https://doi.org/10.3949/ccjm.76a.07002
  • Small fiber neuropathy: A burning problem
    Jinny Tavee, MD and Lan Zhou, MD, PhD
    Cleveland Clinic Journal of Medicine May 2009, 76 (5) 297-305; DOI: https://doi.org/10.3949/ccjm.76a.08070
  • What can we expect from omega-3 fatty acids?
    Eric J. Chan, MD and Leslie Cho, MD
    Cleveland Clinic Journal of Medicine April 2009, 76 (4) 245-251; DOI: https://doi.org/10.3949/ccjm.76a.08042

    Many patients are taking fish oil supplements, either on their own initiative or on their physicians’ advice. Driving this trend is accumulating evidence that these lipids actually reduce cardiovascular risk.

  • Endoscopic therapy of recurrent acute pancreatitis
    Endoscopic therapy of recurrent acute pancreatitis
    Mansour A. Parsi, MD, Tyler Stevens, MD, John A. Dumot, DO and Gregory Zuccaro, MD
    Cleveland Clinic Journal of Medicine April 2009, 76 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.76a.08017

    Endoscopic therapy is an alternative to surgery for some patients with acute recurrent pancreatitis, ie, those whose disease is caused by gallstones or other mechanical processes that can obstruct outflow from the pancreas.

  • Polly can make you sick: Pet bird-associated diseases
    Keels S. Jorn, MD, Kristine M. Thompson, MD, Jan M. Larson, MD and Janis E. Blair, MD
    Cleveland Clinic Journal of Medicine April 2009, 76 (4) 235-243; DOI: https://doi.org/10.3949/ccjm.76a.08018

    Bird owners are at risk of a number of bacterial, protozoal, fungal, viral, and parasitic zoonoses. We review the presentation, evaluation, and basic treatment of these diseases.

  • Psychiatric symptoms of dementia: Treatable, but no silver bullet
    Wihiam Schwab, MD, PhD, Barbara Messinger-Rapport, MD, PhD and Kathy Franco, MD
    Cleveland Clinic Journal of Medicine March 2009, 76 (3) 167-174; DOI: https://doi.org/10.3949/ccjm.76a.07270

    Your 84-year-old patient’s son is distraught. “I know Mom has dementia, but I don’t understand why she cannot relax. Please give her a pill.”

  • Optic neuritis and risk of MS: Differential diagnosis and management
    Benjamín J. Osborne, MD and Nicholas J. Volpe, MD
    Cleveland Clinic Journal of Medicine March 2009, 76 (3) 181-190; DOI: https://doi.org/10.3949/ccjm.76a.07268

    Optic neuritis, a demyelinating inflammatory condition that causes acute vision loss, is associated with multiple sclerosis. Recognizing its classic clinical manifestations early is important so that diagnostic testing and treatment can be started.

  • A new, precise definition of acute myocardial infarction
    A new, precise definition of acute myocardial infarction
    Shaun Senter, MD, MS and Gary S. Francis, MD
    Cleveland Clinic Journal of Medicine March 2009, 76 (3) 159-166; DOI: https://doi.org/10.3949/ccjm.75a.08092

    The updated definition includes subtypes of acute MI, imaging studies supporting the diagnosis, and biomarker thresholds after percutaneous coronary intervention and coronary artery bypass grafting.

  • Cancer and clots: All cases of venous thromboembolism are not treated the same
    Benson Babu, MD, MBA and Teresa L. Carman, MD
    Cleveland Clinic Journal of Medicine February 2009, 76 (2) 129-135; DOI: https://doi.org/10.3949/ccjm.75a.07160

    Idiopathic venous thromboembolism can be the first sign of cancer, although how extensively one should search for cancer in these cases is not clear.

  • Alzheimer disease: Time to improve its diagnosis and treatment
    Alzheimer disease: Time to improve its diagnosis and treatment
    Stephen Salloway, MD, MS and Stephen Correia, PhD
    Cleveland Clinic Journal of Medicine January 2009, 76 (1) 49-58; DOI: https://doi.org/10.3949/ccjm.76a.072178

    Basic research is bringing a much-needed infusion of optimism and urgency to the clinical diagnosis and treatment of Alzheimer disease. Some of its risk factors may be modifiable, and although current drugs offer only modest benefit, true disease-modifying drugs are on the horizon.

Pages